Rocket Pharmaceuticals (RCKT) Times Interest Earned (2016 - 2025)
Rocket Pharmaceuticals' Times Interest Earned history spans 9 years, with the latest figure at -$92.95 for Q4 2025.
- For Q4 2025, Times Interest Earned rose 29.88% year-over-year to -$92.95; the TTM value through Dec 2025 reached -$122.55, up 15.4%, while the annual FY2025 figure was -$122.55, 15.4% up from the prior year.
- Times Interest Earned for Q4 2025 was -$92.95 at Rocket Pharmaceuticals, up from -$110.46 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$22.68 in Q1 2021 and bottomed at -$156.5 in Q2 2024.
- The 5-year median for Times Interest Earned is -$133.76 (2023), against an average of -$122.64.
- The largest annual shift saw Times Interest Earned crashed 928.35% in 2021 before it rose 29.88% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$95.75 in 2021, then crashed by 54.49% to -$147.93 in 2022, then grew by 8.98% to -$134.64 in 2023, then increased by 1.55% to -$132.55 in 2024, then grew by 29.88% to -$92.95 in 2025.
- Per Business Quant, the three most recent readings for RCKT's Times Interest Earned are -$92.95 (Q4 2025), -$110.46 (Q3 2025), and -$150.42 (Q2 2025).